• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Merrimack - Articles and news items

First patient enrolled in Phase 2 study of Onivyde in pancreatic adenocarcinoma

Industry news / 27 October 2015 / Victoria White

The start-up of this study resulted in $62.5M of milestone payments to Merrimack from Baxalta…

 

Webinar: SIFT-MS: A New Tool for Impurity Profiling in Pharmaceutical ProductsLEARN MORE
+ +